Abstract
Steroid hormone levels vary greatly among individuals, between the sexes, with age, and across health and disease states. Nevertheless, what drives variance in steroid hormones and, globally, how steroid hormones vary in an individual over time are not well-studied. To address this fundamental gap in knowledge, we measured the levels of 17 steroid hormones in a sex-balanced cohort of 949 healthy donors ranging in age from 20-69 years. We investigated associations between steroid levels and biological sex, age, clinical and demographic data, genetics, and proteomics. Steroid hormone levels were strongly affected by biological sex and age as hypothesized, but also associated with a surprisingly high number of lifestyle habits. Key among our observations was the broad impact of hormonal birth control in female donors and the relationship with smoking in male donors. Using data collected from a 10-year follow-up of the cohort, we identified significant associations between steroid hormone levels and health status only in male donors. These observations provide a unique and comprehensive resource for steroid hormone level variance in healthy individuals and highlight biological and lifestyle parameters that can impact these levels. Our findings underly the importance of considering parameters, such as sex, age, and potentially gendered behaviors, in preventative health care and the treatment of hormone-related diseases.
One sentence summary Circulating steroid hormone levels are influenced by biological sex, age, lifestyle behaviors, and host genetics.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.milieuinterieur.fr/en/
Funding Statement
The study was supported by the Agence Nationale de la Recherche French government's Invest in the Future programme; reference ANR-10-LABX-69-01. LD received funding from the Labex Milieu Interieur (ANR-10-LABX-69-01). JS received funding from a Marie Curie fellowship (ref 101154579). EMM was part of the Pasteur-Paris University (PPU) International PhD Program, which received funding from the Labex Milieu Interieur (ANR-10-LABX-69-01). MAI and DD were supported by funding from the Agence Nationale de la Recherche (French National Research Agency) ANR-22-CE15-0022-01.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human samples were from the Milieu Interieur cohort, which was approved by the Comite de Protection des Personnes-Ouest 6 on June 13th, 2012, and by the French Agence Nationale de Securite du Medicament (ANSM) on June 22nd, 2012. The study was sponsored by Institut Pasteur (Pasteur ID-RCB Number: 2012-A00238-35) and conducted as a single center interventional study without an investigational product. The original protocol was registered under ClinicalTrials.gov (study# NCT01699893). The samples and data used in this study were formally established as the Milieu Interieur biocollection (NCT03905993), with approvals by the Comite de Protection des Personnes - Sud Mediterranee and the Commission Nationale de l'Informatique et des Libertes (CNIL) on April 11, 2018. Donors gave written informed consent. The 10 year follow up V3 study was approved by the Comite de Protection des Personnes - Nord Ouest III (Committee for the protection of persons) on 27th January 2022, and by the French Agence nationale de securite du medicament (ANSM) on 30th November 201133. The study is sponsored by the Institut Pasteur and was conducted as a single center study without any investigational product. The protocol is registered at ClinicalTrials.gov (study# NCT05381857). Donors gave written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors, or are available online.
